Five ways pharma brands can achieve greater effectiveness
An upsurge in non-rep touchpoints and greater focus on customer centricity have complicated the pharma and biotech commercial model. So how do brand teams and sales forces improve commercial effectiveness and maximize message recall and SFE in this evolving multichannel world?
Five techniques that can help
This white paper shares five of our analytical techniques to help you get the greatest impact out of the digital and personal elements of the new commercial model. Our approaches help improve commercial effectiveness and impact by:
- Improving the accuracy of your competitive position with multidimensional share of voice
- Coordinating multiple touchpoints, with the sales rep at the center
- Combining the optimal set of touchpoints to improve the overall customer experience
- Focusing on impactful messages that have the biggest influence on prescribed behavior
- Concentrating marketing investments on the most effective touchpoints for your critical messages
Our offer to help you leverage these insights in 2019
Deep message recall and impact benchmarks and expertise – including a European syndicated message recall offering – are housed in the cost-effective, operational environment of Ipsos and being used by a broader range of brands than ever before.
Read our white paper to learn some of the challenges that brand teams face, and innovations that are moving brands forward in 2019. Reach out to your Ipsos ATU team about leveraging these insights, or joining the trend of dovetailing message recall and ATU for deeper insights.
